- Report
- August 2022
- 120 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- January 2022
- 111 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- January 2022
- 115 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- January 2022
- 105 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- June 2020
- 111 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- February 2023
- 220 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- March 2022
- 146 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Drug Pipelines
- March 2022
- 73 Pages
Global
From €3819EUR$3,950USD£3,280GBP
- Report
- October 2023
- 84 Pages
Canada
From €3384EUR$3,500USD£2,906GBP
- Report
- October 2023
- 89 Pages
Egypt
From €3384EUR$3,500USD£2,906GBP
- Report
- September 2023
- 83 Pages
Israel
From €3384EUR$3,500USD£2,906GBP
- Report
- August 2023
- 75 Pages
Israel
From €3384EUR$3,500USD£2,906GBP
- Report
- August 2023
- 74 Pages
Canada
From €3384EUR$3,500USD£2,906GBP
- Report
- August 2022
- 117 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- August 2022
- 115 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- August 2022
- 100 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Report
- July 2021
- 50 Pages
China
From €2514EUR$2,600USD£2,159GBP
- Report
- December 2018
- 30 Pages
China
From €2127EUR$2,200USD£1,827GBP
- Report
- April 2020
- 121 Pages
Global
From €3538EUR$3,660USD£3,039GBP
- Drug Pipelines
- June 2022
- 101 Pages
Global
From €10630EUR$10,995USD£9,130GBP
Calcium Channel Blockers (CCBs) are a class of drugs used to treat cardiovascular diseases such as hypertension, angina, and arrhythmias. They work by blocking the entry of calcium ions into the cells of the heart and blood vessels, thus reducing the force of contraction of the heart and dilating the blood vessels. This reduces the workload on the heart and lowers blood pressure. CCBs are also used to treat other conditions such as migraine headaches and Raynaud's phenomenon.
CCBs are generally well tolerated and have few side effects. Common side effects include dizziness, headache, and swelling of the ankles. They may also interact with other medications, so it is important to discuss all medications with a doctor before taking CCBs.
The CCB market is a major component of the cardiovascular drug market. It is a highly competitive market, with many companies offering a variety of CCBs. Some of the major companies in the market include Pfizer, Merck, Novartis, Sanofi, and GlaxoSmithKline. Show Less Read more